Vanina de Verneuil, J.D., currently serves as the Executive Vice President, General Counsel, and Corporate Secretary at Vir Biotechnology Inc., a leading biotechnology company focused on developing innovative treatments for infectious diseases. With a robust legal background and extensive experience in the biotechnology and pharmaceutical industries, de Verneuil has been instrumental in guiding Vir Biotechnology through complex legal landscapes and strategic initiatives. She joined the company in 2017 and has since played a pivotal role in its growth and success, leveraging her expertise to ensure compliance and drive corporate governance. Before her tenure at Vir Biotechnology, de Verneuil held significant positions at several prominent organizations. She previously served as Vice President and General Counsel at Kite Pharma, where she was involved in the company's acquisition by Gilead Sciences, a transaction valued at approximately $11.9 billion. Her career also includes a notable stint at Amgen, where she honed her skills in corporate law and regulatory affairs. De Verneuil's academic credentials are equally impressive; she earned her Juris Doctor from the University of California, Los Angeles School of Law, and holds a Bachelor of Arts in Political Science from the University of California, Berkeley. Her comprehensive understanding of the legal intricacies within the biotech sector has made her an invaluable asset to Vir Biotechnology. In her current role at Vir Biotechnology, de Verneuil oversees all legal matters, including intellectual property management, corporate governance, and compliance. Her strategic vision and leadership have been crucial in navigating the company through the challenges of drug development and commercialization. Under her guidance, Vir Biotechnology has successfully advanced its pipeline of novel therapies, particularly in the fight against infectious diseases such as COVID-19. De Verneuil's contributions extend beyond the legal realm; she is also a key member of the executive team, influencing the company's overall direction and fostering a culture of innovation and ethical responsibility.